Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study

BACKGROUND Proton magnetic resonance spectroscopic imaging (1H-MRSI) studies have reported reductions of N-acetyl aspartate (NAA), a marker of neuronal integrity, in the hippocampal region (HIPPO) and dorsolateral prefrontal cortex (DLPFC) of pharmacologically treated patients with schizophrenia. The purpose of the present study was twofold: to exclude drug treatment as a source of the previous findings and to examine NAA relative concentrations in a unique sample of chronically untreated patients. METHODS We studied 12 medication-free patients, 5 of whom were "drug naive" and symptomatic for a mean of 12 years, and 12 control subjects. Ratios of areas under the metabolite peaks of the proton spectra were determined [i.e., NAA/creatine (CRE), NAA/choline (CHO), CHO/CRE] for multiple cortical and subcortical regions. Hippocampal formation and frontal lobe volumes were also measured to test for correlations with 1H-MRSI data. RESULTS Significant reductions of NAA/CRE and NAA/CHO were found bilaterally in HIPPO and DLPFC. There were no significant changes in CHO/CRE or in NAA ratios in any other area sampled. No significant correlation was found between metabolite ratios, length of illness, and volumes of the hippocampal region and frontal lobe. Mean ratios and effect sizes were not different in chronically ill but still medication-naive patients in comparison with subacute patients and previously studied chronic patients receiving medications. CONCLUSIONS Bilateral reductions of NAA ratios in HIPPO and DLPFC are reliable findings. The findings implicate a relatively localized pattern of neurochemical pathology that does not appear to change with prolonged illness whether medicated or unmedicated.

[1]  P. Renshaw,et al.  Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls , 1996, Schizophrenia Research.

[2]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  Jullie W Pan,et al.  Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T , 1995, Annals of neurology.

[4]  S. Otsuki,et al.  The Influences of Insulin Hypoglycaemic Coma, Repeated Electroshocks, and Chlorpromazine or β-Phenylisopropylmethylamine Administration on the Free Amino Acids in the Brain , 1959 .

[5]  P. Matthews,et al.  Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.

[6]  M. Maier,et al.  Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study , 1996, Schizophrenia Research.

[7]  Kenneth Mark Colby,et al.  Signs and Symptoms , 1981 .

[8]  M. Bárány,et al.  Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients , 1992, Schizophrenia Research.

[9]  Toshiro Fujimoto,et al.  Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report , 1995, Psychiatry Research: Neuroimaging.

[10]  H. Duvernoy The Human Brain , 1999, Springer Vienna.

[11]  G J Barker,et al.  Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia , 1995, Psychological Medicine.

[12]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[13]  B T Hyman,et al.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.

[14]  John P. Stack,et al.  1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates , 1994, Biological Psychiatry.

[15]  P. Narayana,et al.  Time Dependence of N‐Acetyl‐Aspartate, Lactate, and Pyruvate Concentrations Following Spinal Cord Injury , 1996, Journal of neurochemistry.

[16]  August B. Hollingshead,et al.  Social Stratification and Psychiatric Disorders , 1953 .

[17]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[18]  Alessandro Bertolino,et al.  Reproducibility of Proton Magnetic Resonance Spectroscopic Imaging in Patients with Schizophrenia , 1998, Neuropsychopharmacology.

[19]  G Tedeschi,et al.  Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. , 1996, The American journal of psychiatry.

[20]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[21]  I. Jensen,et al.  TEMPORAL LOBE EPILEPSY , 1976, Acta Neurochirurgica.

[22]  G Scarlato,et al.  Central nervous system trans‐synaptic effects of acute axonal injury: a 1h magnetic resonance spectroscopy study , 1995, Magnetic resonance in medicine.

[23]  J A Frank,et al.  Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. , 1997, Cerebral cortex.

[24]  E. Cabanis,et al.  The Human Brain: Surface, Three-Dimensional Sectional Anatomy and Mri , 1991 .

[25]  F. Benes,et al.  Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. , 1986, Archives of general psychiatry.

[26]  J. Lieberman Signs and symptoms. What can they tell us about the clinical course and pathophysiologic processes of schizophrenia? , 1995, Archives of general psychiatry.

[27]  D. Gadian,et al.  Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.

[28]  N C Andreasen,et al.  Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms , 1995 .

[29]  Stephen Ashwal,et al.  Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research , 1998, Pediatric Research.

[30]  J. Vion-Dury,et al.  Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy , 1995, The Lancet.

[31]  B. Miller A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[32]  P Schmalbrock,et al.  Proton Magnetic Resonance Spectroscopy (1H MRS) of the Hippocampal Formation in Schizophrenia: A Pilot Study , 1994, British Journal of Psychiatry.

[33]  M Xue,et al.  Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. , 1994, Radiology.

[34]  D. Jeste,et al.  Hippocampal pathologic findings in schizophrenia. A morphometric study. , 1989, Archives of general psychiatry.

[35]  P. Renshaw,et al.  Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. , 1995, The American journal of psychiatry.

[36]  G J Barker,et al.  The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio , 1993, Magnetic resonance in medicine.

[37]  M. A. Samphilipo,et al.  Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlations , 1994, Magnetic resonance in medicine.

[38]  N. Andreasen,et al.  A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. , 1995, Archives of general psychiatry.

[39]  R. Kuzniecky,et al.  Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging , 1996, Annals of neurology.

[40]  D. Gadian,et al.  H magnetic resonance spectroscopy in the investigation of intractable epilepsy , 1994, Acta neurologica Scandinavica. Supplementum.